In several of these genes that typically harbor somatic mutations in glioma, genome wide association studies (GWAS) have discovered common germline variants that are associated with risk of developing glioma, including variants in EGFR, CDKN2A, TERT, and TP53 [17–22]. This evidence concerns the gene TERT and central nervous system cancer.